Press-release for stocks publishing date 2022 - 03

Prices are updated after-hours

publishing date : 2022 - 03 - 09

save search

Yield10 Bioscience Announces Fourth Quarter and Full Year 2021 Financial Results
Published: 2022-03-09 (Crawled : 23:00) - globenewswire.com
YTEN | $0.252 -7.59% -8.21% 280K

Health Technology

| -93.95% | O: -4.32% H: 36.57% C: 21.9%
financial results bioscience results

red violet Announces Fourth Quarter and Full Year 2021 Financial Results
Published: 2022-03-09 (Crawled : 23:00) - globenewswire.com
RDVT | $17.76 -0.62% -0.62% 24K

Technology Services

| -23.04% | O: -0.85% H: 33.16% C: 19.5%
financial results ces results

NRx Pharmaceuticals Announces Leadership Transition
Published: 2022-03-09 (Crawled : 04:00) - prnewswire.com
NRXP | $3.08 1.99% 1.95% 230K

Manufacturing

| 18.9% | O: 5.12% H: 32.58% C: 23.6%
als ces

Mark Borman appointed Chairman of the Board of USRM
Published: 2022-03-09 (Crawled : 14:30) - us-stemcell.com
USRM | $0.0001 1300.0% 290K

Professional, Scientific, and T...

| -98.65% | O: 0.0% H: 28.38% C: 12.16%
air

AppHarvest named finalist for 2022 SXSW Innovation Awards
Published: 2022-03-09 (Crawled : 22:00) - globenewswire.com
APPH | $0.0666 -16.01% -11.53% 10M

| -98.57% | O: -7.53% H: 26.51% C: 25.12%
awards

Genenta Data Presentation at AACR to Describe On-Target Biological Activity of Temferon™ in Unmethylated Glioblastoma Multiforme
Published: 2022-03-09 (Crawled : 13:00) - globenewswire.com
GNTA | $3.75 -4.23% -4.42% 6.4K

n/a

| -51.92% | O: 1.76% H: 21.46% C: 0.16%
presentation glioblastoma

AgroFresh Solutions Reports Results for Fourth Quarter and Full Year 2021
Published: 2022-03-09 (Crawled : 23:00) - globenewswire.com
AGFS | $3.0 -0.27% 0

Process Industries

| 51.78% | O: -2.03% H: 20.73% C: 9.59%
solutions report results

Vaccinex, Inc. Announces Upcoming Presentation at the 2022 American Association for Cancer Research Meeting Updating the Phase 1b Segment of the KEYNOTE-B84 Study of Pepinemab in Combination with KEYTRUDA (pembrolizumab) in Patients with Recurrent or Metastatic Head and Neck Cancer
Published: 2022-03-09 (Crawled : 23:00) - globenewswire.com
VCNX | $4.8 -2.76% 7.9K

Health Technology

| 340.37% | O: 1.83% H: 18.92% C: 17.12%
america ema phase 1b research presentation pepinemab phase 1 keytruda dating cancer head and neck vaccine phase 2b

Vaccinex, Inc. Announces Upcoming Presentation at the 2022 American Association for Cancer Research Meeting Updating the Phase 1b Segment of the KEYNOTE-B84 Study of Pepinemab in Combination with KEYTRUDA (pembrolizumab) in Patients with Recurrent or Meta
Published: 2022-03-09 (Crawled : 16:20) - ir.vaccinex.com
VCNX | $4.8 -2.76% 7.9K

Health Technology

| 340.37% | O: 1.83% H: 18.92% C: 17.12%
america ema phase 1b research presentation pepinemab phase 1 keytruda dating cancer vaccine phase 2b

Altitude International Announces Partnership with the Largest Youth Soccer Club Network in the World
Published: 2022-03-09 (Crawled : 14:30) - prnewswire.com
ALTD | $0.0004 11150.0% 300

Arts, Entertainment, and Recrea...

| -99.2% | O: 0.0% H: 17.8% C: 2.2%
partnership ces work tiona

Registration of Share Capital Increase in IDEX Biometrics - 9 March 2022
Published: 2022-03-09 (Crawled : 11:00) - globenewswire.com
IDBA | $4.88 1.67% 0.0% 9

Manufacturing

| -65.99% | O: 1.39% H: 16.84% C: 16.84%

Assure Holdings Sets Fourth Quarter and Full Year 2021 Conference Call for Monday, March 14, 2022, at 8:00 a.m. ET
Published: 2022-03-09 (Crawled : 23:00) - globenewswire.com
IONM | $0.4547 -28.54% -39.94% 420K

Manufacturing

| -99.44% | O: 0.18% H: 16.07% C: 7.14%
day conference set

Vera Bradley Announces Fourth Quarter and Fiscal Year 2022 Results
Published: 2022-03-09 (Crawled : 23:00) - globenewswire.com
VRA 4 | $6.44 -0.46% -0.47% 270K

Consumer Non-Durables

| -5.89% | O: -7.07% H: 15.37% C: 12.04%
ces results

Trevi Therapeutics to Report Q4 and Year End 2021 Financial Results and Provide a Corporate Update on March 17, 2022
Published: 2022-03-09 (Crawled : 22:00) - biospace.com/
TRVI | $2.82 5.03% 4.79% 140K

Health Technology

| 69.18% | O: 5.03% H: 14.97% C: 2.99%
financial results therapeutics report results

9 Meters Biopharma to Present at the Oppenheimer 32nd Annual Healthcare Conference
Published: 2022-03-09 (Crawled : 14:00) - biospace.com/
NMTR | $0.0722 -42.97% -67.9% 10M

Health Technology

| -87.11% | O: 0.12% H: 14.21% C: 12.22%
health biopharma thc conference

High Tide Subsidiary Blessed CBD Enters German Market
Published: 2022-03-09 (Crawled : 11:00) - hightideinc.com
HITI | $2.255 2.04% 2.0% 730K

Manufacturing

| -39.07% | O: 6.68% H: 13.98% C: 8.92%
cbd germany

Ampio Pharmaceuticals to Participate at the 34th Annual Roth Conference
Published: 2022-03-09 (Crawled : 14:30) - ampiopharma.com
AMPE | $0.242 0.0% 15K

Health Technology

| -42.86% | O: 2.62% H: 13.69% C: 13.69%
als conference

Acadia Pharmaceuticals Announces August 4, 2022 Action Date for Resubmitted Supplemental New Drug Application for NUPLAZID® (pimavanserin) for the Treatment of Alzheimer’s Disease Psychosis
Published: 2022-03-09 (Crawled : 21:00) - biospace.com/
ACAD | $16.82 -1.47% -1.49% 3.5M

Health Technology

| -26.45% | O: 2.14% H: 13.64% C: 7.87%
nuplazid new drug alzheimer treatment als application drug disease alzheimer’s alzheimer's disease alzheimer's

Oatly Reports Fourth Quarter and Full Year 2021 Financial Results
Published: 2022-03-09 (Crawled : 12:30) - globenewswire.com
OTLY | $0.9556 3.07% 2.98% 1.2M

Manufacturing